Topic: SPI-1620 in a Phase I Study in combination with Docetaxel

Saw this tonight and thought it was very interesting. I am reluctant to post stock market related links in case people think I may have a financial interest in the company involved in the link, but I have absolutely no financial interest in this company whatsoever. Just wanted to say that.

Spectrum Pharmaceuticals Announces Impressive Responses in Difficult to Treat Carcinomas with SPI-1620 in a Phase I Study

" Encouraging antitumor activity was also seen in patients with cholangiocarcinoma, transitional cell urothelial carcinoma, and ovarian cancer." … 2011-09-19


Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.